Bavarian Nordic to Present at Jefferies 2011 Global Healthcare Conference in London
(Thomson Reuters ONE) -
KVISTGAARD, Denmark, September 20, 2011 - Bavarian Nordic (NASDAQ OMX: BAVA)
announced today that it will present at the Jefferies 2011 Global Healthcare
Conference in London on Tuesday, September 27, 2011 at 12:20 p.m. BST.
The presentation will be held by Anders Hedegaard, President & CEO of Bavarian
Nordic. The slides from the presentation will subsequently be available on the
company's website: www.bavarian-nordic.com/investor
About Bavarian Nordic
Bavarian Nordic is a vaccine-focused biotechnology company developing and
producing novel vaccines for the treatment and prevention of life-threatening
diseases with a large unmet medical need. The company's clinical pipeline
targets cancer and infectious diseases, and includes seven development
programmes. Two programmes are under preparation for Phase 3: PROSTVAC®, a
therapeutic vaccine for advanced prostate cancer is being developed under a
collaboration agreement with the National Cancer Institute, and IMVAMUNE®, a
third-generation smallpox vaccine is being developed under a contract with the
US government.
Bavarian Nordic is listed on NASDAQ OMX Copenhagen under the symbol BAVA.
For more information please visit www.bavarian-nordic.com
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Bavarian Nordic A/S via Thomson Reuters ONE
[HUG#1548255]
Unternehmensinformation / Kurzprofil:
Datum: 20.09.2011 - 14:38 Uhr
Sprache: Deutsch
News-ID 67733
Anzahl Zeichen: 1920
contact information:
Town:
Kvistgård
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 170 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Bavarian Nordic to Present at Jefferies 2011 Global Healthcare Conference in London"
steht unter der journalistisch-redaktionellen Verantwortung von
Bavarian Nordic A/S (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
